In previous studies, a group of literatures have reported that stathmin-1, HOTAIR and SUMO1P3 [30]–[32] were correlated with metastasis and prognosis in gastric cancer patients, but it was notable that the testing of these biomarkers were usually high-cost, and conventionally require the fresh gastric cancer tissues. This evidence concerns the gene STMN1 and gastric cancer.